Clinical efficiency and safety of riamilovir under various dosage regimens for treatment of acute respiratory viral infections in adults

Aim. To evaluate the clinical efficacy and safety of antiviral drug riamilovir in patients with acute respiratory viral infections (ARVI) of non-coronavirus (SARS-CoV-2) etiology with different dosing regimens. Materials and methods. The study included 150 patients with ARVI aged 18–27 years (50...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Konstantin V. Zhdanov, Oleg V. Maltsev, Kristina V. Kasyanenko, Konstantin V. Kozlov, Vitalii S. Sukachev, Nikolai I. Lvov, Valerian V. Sharabkhanov, Alexander A. Litvinov
Format:	Artigo
Sprog:	Russo
Udgivet:	"Consilium Medicum" Publishing house 2023-12-01
Serier:	Терапевтический архив
Fag:	acute respiratory viral infections acute respiratory infections riamilovir nucleoside analogues influenza
Online adgang:	https://ter-arkhiv.ru/0040-3660/article/viewFile/623486/139201
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!